Neuropeptide Y (NPY) has been shown to depress hyperexcitable activity that
has been acutely induced in the normal rat brain. To test the hypothesis t
hat NPY can also reduce excitability in the chronically epileptic human bra
in, we recorded intracellularly from dentate granule cells in hippocampal s
lices from patients with hippocampal seizure onset. NPY had a potent and lo
ng-lasting inhibitory action on perforant path-evoked excitatory responses.
In comparison, the group 3 metabotropic glutamate receptor agonist L-2-ami
no-3-phosphonobutyric acid (L-AP4) evoked a mild and transient decrease. NP
Y-containing axons were found throughout the hippocampus, and in many epile
ptic patients were reorganized, particularly in the dentate molecular layer
, NPY may therefore play a beneficial role in reducing granule cell excitab
ility in chronically epileptic human tissue, and subsequently limit seizure
severity.